Email
Mot de passe
Pour plus de facilité, laissez cette case cochée. Sur les appareils partagés, nous vous conseillons de vous déconnecter d'Euroquity à la fin de votre utilisation
Email

Vous allez recevoir un email pour créer un nouveau mot de passe

Localisation

Choisissez votre pays

et votre langue

Bonjour ,

Bienvenue sur votre profil personnel. Votre carte de visite professionnelle présente votre activité principale. Elle sera visible sur EuroQuity.

% complété

%

medal 1
Ce profil est validé par 1 label.

Company

Glycobond

Glycobond_logo
5
EQ SCORE

L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.

Linköping, Östergötland, Sweden

Send a message

Anglais

Glycobond

Anglais

Glycobond develops and produces carbohydrate-binding reagents for detection of disease-specific biomarkers.

It is well known that carbohydrate structures that are attached to proteins in the body undergo specific changes during disease processes such as cancer and inflammation. Glycobond uses recombinant technology to produce carbohydrate-binding peptides with defined specificities for use primarily in diagnosis and monitoring of liver disesases and...

See more

Glycobond develops and produces carbohydrate-binding reagents for detection of disease-specific biomarkers.

It is well known that carbohydrate structures that are attached to proteins in the body undergo specific changes during disease processes such as cancer and inflammation. Glycobond uses recombinant technology to produce carbohydrate-binding peptides with defined specificities for use primarily in diagnosis and monitoring of liver disesases and cancer.

Our first product is HepaCheC®, an assay for detecting primary liver cancer at an early stage. The assay is ELISA-based and can be run in any clinical laboratory, is performed on a simple blood sample and will be clinically evaluated during 2017. Initial clinical tests have shown high specificity and sensitivity for detection of primary hepatocellular carcinoma (HCC, liver cancer). 

The company was founded in 2011 as a spin-off from research performed at Linköping University. 

Team member(s)

Your request has been sent
Join this organization
Your request has been sent

Our network

Your request has been sent
Join this network
Your message has been sent

Certifications

Seal of Excellence
The Seal of Excellence is a quality label awarded to project proposals submitted to Horizon 2020 which succeeded a highly competitive evaluation process by independent experts, but did not received funding due to budget limits. This quality label is a guarantee for investors to find high standard project proposals from European SMEs with growth potential.
1113 Entities

Communities